Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Diamond Biotechnology Co., Ltd. (6815) Financial Statements

Diamond Biotechnology Co., Ltd. Financial Overview

Diamond Biotechnology Co., Ltd.'s market cap is currently NT$790.14M. The company's EPS TTM is NT$-1.21; its P/E ratio is -15.62; and it has a dividend yield of 0.84%. Diamond Biotechnology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 501.49MNT$ 768.25MNT$ 616.10MNT$ 434.84MNT$ 395.20M
Gross ProfitNT$ 155.25MNT$ 330.71MNT$ 289.59MNT$ 184.32MNT$ 187.88M
Operating IncomeNT$ -74.19MNT$ 112.75MNT$ 63.91MNT$ 46.41MNT$ 48.09M
EBITDANT$ -45.94MNT$ 131.16MNT$ 116.17MNT$ 99.04MNT$ 112.72M
Net IncomeNT$ -70.31MNT$ 73.20MNT$ 46.74MNT$ 33.39MNT$ 41.92M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 209.76MNT$ 246.10MNT$ 78.52MNT$ 98.47MNT$ 51.21M
Total AssetsNT$ 868.96MNT$ 1.06BNT$ 798.91MNT$ 630.46MNT$ 540.94M
Total DebtNT$ 233.80MNT$ 251.58MNT$ 352.69MNT$ 214.90MNT$ 180.04M
Net DebtNT$ 87.70MNT$ 95.48MNT$ 274.17MNT$ 116.43MNT$ 128.83M
Total LiabilitiesNT$ 327.12MNT$ 433.28MNT$ 452.52MNT$ 327.77MNT$ 267.83M
Stockholders' EquityNT$ 541.83MNT$ 623.05MNT$ 346.39MNT$ 302.69MNT$ 273.11M
Cash Flow
Free Cash FlowNT$ -3.22MNT$ 3.50MNT$ -155.72MNT$ 84.57MNT$ -19.25M
Operating Cash FlowNT$ -2.08MNT$ 33.70MNT$ 40.90MNT$ 157.53MNT$ 5.64M
Investing Cash FlowNT$ 36.99MNT$ -81.89MNT$ -196.31MNT$ -132.57MNT$ -52.11M
Financing Cash FlowNT$ -44.33MNT$ 125.98MNT$ 135.46MNT$ 22.29MNT$ 35.32M

Currency in TWD

Diamond Biotechnology Co., Ltd. Earnings and Revenue History

-500M0500M1B-20 %0 %20 %40 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Diamond Biotechnology Co., Ltd. Liabilities to Assets

0400M800M1.2B0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Diamond Biotechnology Co., Ltd. Cash Flow

-300M-200M-100M0100M200M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Diamond Biotechnology Co., Ltd. Forecast EPS vs Actual EPS

Earnings >